MAXHEALTHBSEMax Healthcare Institute LtdLowNeutral
Announced Thu, 21 May · 16:43 IST

Re-appointment of Cost Auditor

Management Changes View source PDF

MAXHEALTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-8.5%1-day move
₹1093.15
prior close
₹1068.25
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.7-3.9-4.7-4.6-8.5-9.2-9.0-11.7-13.7-11.7-5.8-0.0-1.1
Up moveDown movePending
AI summary

Max Healthcare Institute reported strong FY2026 results with consolidated revenue of Rs 8,37,345 lakhs, up 19% from Rs 7,02,846 lakhs in FY2025. Full year consolidated profit after tax stood at Rs 1,44,241 lakhs, representing a 34% YoY increase. Annualized EPS improved to Rs 14.83 from Rs 11.07. The Board also recommended a final dividend of Rs 2 per share (20% on face value Rs 10), approved re-appointment of Cost Auditors M/s Chandra Wadhwa & Co. for FY27, and approved construction of a new 712-bed super specialty hospital in Lucknow. Additionally, the Board approved shifting the registered office from Mumbai to Gurugram and re-classification of Radiant Life Care Hospital Foundation from Promoter Group to Public category, subject to shareholder approval.

Likely market impact

Strong financial performance with 19% revenue growth and 34% PAT growth is positive for shareholders. The dividend and new hospital construction signal continued investment in growth. The promoter re-classification reduces promoter group holding in public float, which may affect stock dynamics.